Tower Research Capital LLC (TRC) - AC IMMUNE SA ownership

AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 35 filers reported holding AC IMMUNE SA in Q4 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of AC IMMUNE SA
ValueSharesWeighting
Q2 2024$12,265
-28.9%
3,074
-47.3%
0.00%
Q1 2024$17,257
+343.6%
5,830
+649.4%
0.00%
Q4 2023$3,890
-93.0%
778
-96.0%
0.00%
-100.0%
Q3 2023$55,968
+4758.3%
19,638
+4935.4%
0.00%
Q2 2023$1,152
+115100.0%
390
-29.5%
0.00%
Q1 2023$1
-100.0%
553
-83.4%
0.00%
Q3 2022$11,000
+22.2%
3,334
+38.2%
0.00%
Q2 2022$9,000
-70.0%
2,412
-68.5%
0.00%
Q1 2022$30,000
+7.1%
7,657
+39.4%
0.00%
Q4 2021$28,000
-62.7%
5,491
-50.9%
0.00%
-100.0%
Q3 2021$75,000
+316.7%
11,191
+404.3%
0.00%
Q2 2021$18,000
-52.6%
2,219
-55.5%
0.00%
-100.0%
Q1 2021$38,000
+11.8%
4,988
-24.7%
0.00%0.0%
Q4 2020$34,000
+3.0%
6,625
-2.4%
0.00%
Q3 2020$33,000
-26.7%
6,788
+0.2%
0.00%
-100.0%
Q2 2020$45,0006,774
+56350.0%
0.00%
Q1 2020$0
-100.0%
12
-99.9%
0.00%
-100.0%
Q4 2019$75,000
+21.0%
8,740
-29.8%
0.01%
+50.0%
Q3 2019$62,000
+51.2%
12,454
+52.5%
0.00%
+100.0%
Q1 2019$41,000
+28.1%
8,164
+103.2%
0.00%0.0%
Q3 2018$32,000
+357.1%
4,018
+631.9%
0.00%
+100.0%
Q4 2017$7,000
-74.1%
549
-82.0%
0.00%
-66.7%
Q2 2017$27,0003,0450.00%
Other shareholders
AC IMMUNE SA shareholders Q4 2023
NameSharesValueWeighting ↓
BVF INC/IL 9,819,434$54,498,0005.95%
Prosight Management, LP 563,900$3,130,0001.58%
Artal Group S.A. 1,000,000$5,550,0000.22%
Temasek Holdings (Private) Ltd 2,614,095$14,508,0000.10%
BOOTHBAY FUND MANAGEMENT, LLC 111,754$620,0000.06%
COHEN LAWRENCE B 13,350$74,0000.05%
Tekla Capital Management LLC 171,813$954,0000.04%
Athanor Capital, LP 42,100$234,0000.03%
APPLETON PARTNERS INC/MA 15,360$85,0000.01%
A.R.T. Advisors, LLC 30,985$172,0000.01%
View complete list of AC IMMUNE SA shareholders